Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2007-08-22
2010-10-12
Rawlings, Stephen L (Department: 1643)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C530S350000, C530S387100, C530S387300, C530S388100, C530S388300, C530S387900, C424S133100, C424S159100, C424S139100, C536S023500, C435S069100, C435S320100, C435S325000, C435S339000, C435S331000
Reexamination Certificate
active
07811568
ABSTRACT:
Humanized monoclonal antibodies against the vaccinia virus B5R surface antigen. The antibodies are effective in treating smallpox infection. Also disclosed are nucleic acids that encode the heavy and light chains of such antibodies and cells that express them.
REFERENCES:
patent: 6451309 (2002-09-01), Hooper et al.
patent: 6620412 (2003-09-01), Hooper et al.
patent: 2002/0009447 (2002-01-01), Hooper et al.
patent: 2003/0022226 (2003-01-01), Hooper et al.
Greenspan et al. (Nature Biotechnology. 1999; 7: 936-937).
Mariuzza et al. (Annu. Rev. Biophys. Biophys. Chem. 1987; 16: 139-159).
Gussow et al. (Methods in Enzymology. 1991; 203: 99-121).
Giusti et al. (Proc. Natl. Acad. Sci. USA. May 1987; 84 (9): 2926-2930).
Chien et al. (Proc. Natl. Acad. Sci. USA. Jul. 1989; 86 (14): 5532-5536).
Caldas et al. (Mol. Immunol. May 2003; 39 (15): 941-952).
Lustig et al., “Combinations of Polyclonal or Monoclonal Antibodies to Proteins of the Outer Membranes of the Two Infectious Forms of Vaccinia Virus Protect Mice against a Lethal Respiratory Challenge,” Journal of Virology, 79(21):13454-13462 (2005).
Ramirez et al., “Administration to Mice of a Monoclonal Antibody that Neutralizes the Intracellular Mature Virus Form of Vaccinia Virus Limits Virus Replication Efficiently under Prophylactic and Therapeutic Conditions,” Journal of General Virology, 83:1059-1067 (2002).
Schmelz et al., “Assembly of Vaccinia Virus: The Second Wrapping Cisterna Is Derived from the Trans Golgi Network,” Journal of Virology, 68(1):130-147 (1994).
Bell et al., “Antibodies against the Extracellular Enveloped Virus B5R Protein are Mainly Responsible for the EEV Neutralizing Capacity of Vaccinia Immune Globulin,”Virology. 01 vol. 325, No. 2, pp. 425-431; see entire document (e.g., the abstract), 2004.
Sawyer et al., “Antibodies for the Prevention and Treatment of Viral Diseases,”Antiviral Res. vol. 47, No. 2, pp. 57-77, see entire document (e.g., the abstract), 2000.
Jouvin Marie-Helene
Kinet Jean-Pierre
Occhiuti Rohlicek & Tsao LLP
Quercegen Pharma
Rawlings Stephen L
LandOfFree
Smallpox monoclonal antibody does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Smallpox monoclonal antibody, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Smallpox monoclonal antibody will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4205584